CN114042119A - Medicine for quickly healing surgical incision and promoting wound muscle growth - Google Patents
Medicine for quickly healing surgical incision and promoting wound muscle growth Download PDFInfo
- Publication number
- CN114042119A CN114042119A CN202111383081.4A CN202111383081A CN114042119A CN 114042119 A CN114042119 A CN 114042119A CN 202111383081 A CN202111383081 A CN 202111383081A CN 114042119 A CN114042119 A CN 114042119A
- Authority
- CN
- China
- Prior art keywords
- parts
- incision
- medicine
- weight portions
- healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Abstract
The medicine for fast healing of operation incision and promoting wound muscle growth is prepared with dragon's blood 5-10 weight portions, rosin 10-15 weight portions, pearl powder 10-15 weight portions, bezoar 5-10 weight portions, catechu 10-20 weight portions, tendril-leaved fritillary bulb 5-10 weight portions, borneol 10-15 weight portions, musk 5-10 weight portions, notoginseng 5-10 weight portions, mint 10-20 weight portions, viola 5-10 weight portions and myrrh 10-20 weight portions, and has solved the problem of wound healing difficulty.
Description
Technical Field
The invention relates to the technical field of wound healing medicines, in particular to a medicine for quickly healing an operation incision and promoting the growth of wound muscles.
Background
The skin is the largest organ of the human body, has very important physical, chemical and biological barrier functions, plays roles of preventing the loss of substances such as water, electrolyte and the like, has functions of immunity, sensing and the like, and plays very important roles in maintaining the stability of the internal environment and preventing the invasion of microorganisms. Once the skin is damaged, the body is infected by bacteria, the metabolism is increased, the water and protein are excessively lost, the endocrine and immune system are dysfunctional, and the like, and the life can be threatened when the body is serious. Therefore, after the skin is damaged, the wound needs to be treated accordingly to repair the damaged skin. The mildest wounds are limited to the epidermal layer of the skin and heal by epithelial regeneration, the more serious ones have skin and subcutaneous tissue breaks and have wounds, and the more serious wounds can be muscle, tendon, nerve breaks and fractures. The healing time of the surgical incision which is common clinically is long, and the healing of the incision is generally performed in the operations of the head and the face, which is about 4 to 5 days; the healing time of the surgical incision on both upper limbs is probably 10 days; the time of the surgical incision of the lower limb is about 9 days, and after the surgery is finished, the muscle at the surgical wound can shrink, so that a large scar can be left at the wound, and the existing drug effect of promoting the wound healing is poor.
Disclosure of Invention
In order to overcome the above defects of the prior art, embodiments of the present invention provide a formulation for promoting the healing of surgical incisions and the growth of subcutaneous collagen-rich fat and a preparation method thereof, which can solve the problems of rapidly healing surgical incisions and promoting the rapid tissue regeneration of the body in a short time.
The technical purpose of the invention is realized by the following technical scheme:
the medicine for rapidly healing the surgical incision and promoting the growth of wound muscles comprises, by weight, 5-10 parts of dragon's blood, 10-15 parts of rosin, 10-15 parts of pearl powder, 5-10 parts of bezoar, 10-20 parts of sedum aizoon, 5-10 parts of bulbus fritilariae, 10-15 parts of borneol, 5-10 parts of musk, 5-10 parts of pseudo-ginseng, 10-20 parts of mint, 5-10 parts of viola and 10-20 parts of myrrh.
The medicine for rapidly healing the surgical incision is prepared by the following method:
the first step is as follows: selecting the medicinal materials with better quality for later use;
the second step is that: after the medicinal materials are dried, the drying degree of the medicinal materials is detected by a dynamic dryness analyzer after the drying is finished, the medicinal materials which do not meet the dryness standard are picked out for drying again, and the medicinal materials with the composite standard are placed in a sealed container for later use;
the third step: placing the above medicinal materials except Borneolum Syntheticum in a sealed container into a stirring barrel, and stirring at a speed of 50-60 rpm for more than fifteen minutes until the medicinal materials are uniformly stirred and mixed;
the fourth step: adding the uniformly mixed medicinal materials into a grinder to be processed into medicinal powder, and adding borneol into the grinder to be processed into medicinal powder;
the fifth step: sieving the ground medicinal powder with a 250-mesh sieve uniformly, and pouring the large-particle medicinal powder left on the 250-mesh sieve into the grinding machine again to be ground together with the next batch of medicines again after the screening is finished;
and a sixth step: adding sesame oil into the uniformly sieved medicinal powder, heating in a water-proof manner at 100 ℃ for 5 hours, stirring continuously, pouring into an earthen pot, heating to 300 ℃ for 20 minutes, and stirring continuously. Cooling, precipitating, filtering, and extracting medicinal oil;
the seventh step: adding Borneolum Syntheticum powder into the medicinal oil, stirring, and filling into corresponding container;
eighth step: extracting the medicinal oil in the finished product according to the proportion of 5 percent for experimental detection.
Has the advantages that: the dragon's blood, the rosin, the borneol and the myrrh have the effects of promoting granulation and relieving pain, the musk and the pseudo-ginseng have the effects of promoting blood circulation and relieving pain, the bezoar has the effect of clearing away heat and toxic materials, and the mint and the viola have the effects of diminishing inflammation and resisting bacteria, so that the medicine has the effects on wounds, can start granulation and healing within 2-3 days after being coated on surgical incisions, has a good effect in clinical experiments, and can be widely applied to clinic.
Detailed Description
The following description is only a preferred embodiment of the present invention, and the protection scope is not limited to the embodiment, and any technical solution that falls under the idea of the present invention should fall within the protection scope of the present invention. It should also be noted that modifications and embellishments within the scope of the invention may occur to those skilled in the art without departing from the principle of the invention.
The invention relates to a medicine for promoting the healing of surgical incision and promoting the growth of wound muscle and subcutaneous collagen-rich fat.
The first embodiment is as follows:
the medicine comprises 5 parts by weight of dragon's blood, 10 parts by weight of rosin, 10 parts by weight of pearl powder, 5 parts by weight of bezoar, 10 parts by weight of sedum aizoon, 5 parts by weight of bulbus fritillariae cirrhosae, 10 parts by weight of borneol, 5 parts by weight of musk, 5 parts by weight of pseudo-ginseng, 10 parts by weight of mint, 5 parts by weight of viola and 10 parts by weight of myrrh.
Example two:
the medicine comprises 6 parts by weight of dragon's blood, 11 parts by weight of rosin, 11 parts by weight of pearl powder, 6 parts by weight of bezoar, 12 parts by weight of sedum aizoon, 6 parts by weight of bulbus fritillariae cirrhosae, 11 parts by weight of borneol, 6 parts by weight of musk, 6 parts by weight of pseudo-ginseng, 12 parts by weight of mint, 7 parts by weight of viola and 13 parts by weight of myrrh.
Example three:
the medicine comprises, by weight, 9 parts of dragon's blood, 14 parts of rosin, 14 parts of pearl powder, 9 parts of bezoar, 18 parts of sedum, 9 parts of bulbus fritillariae cirrhosae, 14 parts of borneol, 9 parts of musk, 9 parts of pseudo-ginseng, 16 parts of mint, 9 parts of viola and 17 parts of myrrh.
Example four:
the medicine comprises, by weight, 10 parts of dragon's blood, 15 parts of rosin, 15 parts of pearl powder, 10 parts of bezoar, 20 parts of sedum, 10 parts of bulbus fritillariae cirrhosae, 15 parts of borneol, 10 parts of musk, 10 parts of pseudo-ginseng, 20 parts of mint, 10 parts of viola and 20 parts of myrrh.
The efficacy of each medicinal material is explained as follows: 1. dragon's blood: promoting blood circulation, relieving pain, removing blood stasis, stopping bleeding, healing sore, and promoting granulation; 2. rosin: dispelling pathogenic wind and removing dampness, expelling pus and drawing out pus, promoting granulation and relieving pain; 3. pearl powder: promoting granulation; 4. bezoar: clearing away heat and toxic materials; 5. tendril-leaved fritillary bulb: anti-ulcer; 6. borneol: clearing heat and relieving pain; 7. the method comprises the following steps Musk: promoting blood circulation, dredging channels, and relieving pain; 8. pseudo-ginseng: stasis dissipating, bleeding stopping, swelling subsiding and pain relieving; 9. mint: anti-inflammatory and antibacterial; 10. yellow organ: purging pathogenic fire, removing toxic substances, clearing away heat, removing pathogenic fire, and resisting bacteria and inflammation; 11. myrrh: dispel stasis, relieve pain, resolve swelling and promote tissue regeneration.
The medicine for rapidly healing the surgical incision is prepared by the following method:
the first step is as follows: selecting the medicinal materials with better quality for later use;
the second step is that: after the medicinal materials are dried, the drying degree of the medicinal materials is detected by a dynamic dryness analyzer after the drying is finished, the medicines which do not meet the dryness standard are selected out for drying again, and the medicines with the composite standard are placed in a sealed container for standby;
the third step: placing the above medicinal materials except Borneolum Syntheticum in a sealed container into a stirring barrel, and stirring at a speed of 50-60 rpm for more than fifteen minutes until the medicinal materials are uniformly stirred and mixed;
the fourth step: adding the uniformly mixed medicinal materials into a grinder to be processed into medicinal powder, and adding borneol into the grinder to be processed into medicinal powder;
the fifth step: sieving the ground medicinal powder with a 250-mesh sieve uniformly, and pouring the large-particle medicinal powder left on the 250-mesh sieve into the grinding machine again to be ground together with the next batch of medicines again after the screening is finished;
and a sixth step: adding sesame oil into the uniformly sieved medicinal powder, heating in a water-proof manner at 100 ℃ for 5 hours, stirring continuously, pouring into an earthen pot, heating to 300 ℃ for 20 minutes, and stirring continuously. Cooling, precipitating, filtering, and extracting medicinal oil;
the seventh step: adding Borneolum Syntheticum powder into the medicinal oil, stirring, and filling into corresponding container;
eighth step: extracting the medicinal oil in the finished product according to the proportion of 5 percent for experimental detection.
The following are experimental data for the above drugs:
experiment one:
60 mice (30 g) were randomly divided into 6 groups, 3 blank controls each, labeled A, B, C three groups (no medication); three groups of 3 experiments, labeled D, E, F (drug used as per example, wound infusion).
The experimental steps are as follows:
injecting 5% chloral hydrate 0.08mL (10g) into abdominal cavity for anesthesia, shaving hair on mouse back with a shaver, applying depilatory cream with an area of about 3cmX3cm, applying depilatory cream, shaving hair after 5min, wiping the shaved hair with a cotton ball dipped in water, wiping with 75% ethanol for sterilization, incising a skin incision with a length of about 1.5cm with a sterile scalpel until the wound is deep to fascia, gently shaving the fascia at about 1cm around and in front of the incision with a scalpel to completely separate the skin and muscle of the shaved part, wiping the wound mucus with a sterile cotton swab to dry, suturing 3 blank control groups with medical 2.5 × 10 needles after completion, injecting medicinal liquid into the incision of 3 experimental groups, wiping the incision with a sterile cotton swab after 5min, wiping the incision, suturing the medicinal liquid with medical 2.5 × 10 needles, and wiping the incision with 75% ethanol. After 12 hours, the incisions of the 6 groups of mice had completely healed, the suture was gently cut with a sterile surgical scissors, and on the 1 st, 3 rd and 5 th days, the incisions of the A, D th, B, E th and C, F th groups were made, respectively, and the adhesion between the skin and the muscle was observed to heal.
Wound healing status for each experimental group:
1. the incision of the A group (without medicine) and the D group (with medicine) is cut on the 1 st day, the skin and the muscle of the A group (without medicine) are completely separated, no adhesive healing sign exists, 30% of the skin and the muscle in the deep part of the incision of the D group (with medicine) are adhered, mucus is distributed around the rest incisions, and the mucus is transparent and has no peculiar smell.
2. The incision of the group B (without medicine) and the group E (with medicine) is cut on the 3 rd day, the skin and the muscle of the group B (without medicine) are completely separated, no adhesive healing sign exists, 6 skin and muscle of the group D (with medicine) are adhered and healed, 70% of skin and muscle in the depth of the rest 4 incisions are adhered, mucus is fully distributed around the rest incisions, and the mucus is transparent and has no peculiar smell.
3. On day 5, incisions were made between group C (no drug) and group F (drug), with the skin and muscle completely detached from group C (no drug) and without any signs of adhesive healing, and with complete adhesive healing between the skin and muscle of group F (drug).
4. Groups of mice that did not heal were cut and the suture refilled and the incision was cut on day 7 and had all the adhesive healed.
Experiment two:
60 mice (55 g) were randomly divided into 6 groups, 3 placebo groups, labeled A, B, C groups (no medication); three groups of 3 experiments, labeled D, E, F (dual drug per example, wound infusion).
The experimental steps are as follows:
injecting 5% chloral hydrate 0.08mL (10g) into abdominal cavity for anesthesia, shaving hair on mouse back with a shaver, applying depilatory cream with an area of about 3cmX3cm, applying depilatory cream, shaving hair after 5min, wiping the shaved hair with a cotton ball dipped in water, wiping with 75% ethanol for sterilization, incising a skin incision with a length of about 2cm with a sterile scalpel until the wound is deep to fascia, gently shaving the fascia at about 1cm depth around the incision and at about 1cm depth around the front and back of the incision to completely detach the skin and muscle of the shaved part, incising a 0.5cm incision with a length of 1cm depth to the incision muscle with a scalpel, wiping the wound mucus with a sterile cotton swab to dry, suturing the inner and outer incisions of 3 blank control groups with 2.5X 10 needle thread (two times of suture), injecting medicinal liquid into the muscle incisions of 3 experimental groups, wiping the incisions with a sterile cotton swab after 5min, and drying the cut the medicinal liquid in the incisions, the internal and external incisions are then sutured with medical 2.5 x 10 needle thread (two times of suturing), and the incisions are wiped clean with 75% ethanol after suturing. After 12 hours, the skin incisions of 6 groups of mice were completely healed, the suture was gently cut with a sterile surgical scissors, and the outer skin incisions of A, D, B, E and C, F groups were cut on days 1, 3 and 5, respectively, and the adhesion between the inner incision muscles was observed.
Wound healing status for each experimental group:
1. on day 1, incisions were made between group A (no drug) and group D (drug), with no signs of adhesion healing between the muscles of the incision in group A (no drug) and signs of atrophy on both sides of the incision, and with substantial adhesion healing between the muscles of the incision in group D (drug), with full and no atrophy on both sides of the incision.
2. On day 3, incisions were made between group B (no drug) and group E (drug), with the muscles of the incision in group B (no drug) having essentially bonded healing but the muscles on both sides of the incision having signs of atrophy, and group D (drug) having 8 muscles with essentially bonded healing between the muscles of the incision, and the remaining 2 muscles having essentially bonded healing between the muscles of the incision, with the muscles on both sides of the incision being full and without atrophy.
3. And on the 5 th day, incisions of the C group (without medicine) and the F group (with medicine) are cut, 6 muscles with the inner incision in the C group (without medicine) are completely bonded and healed, the other 4 muscles with the inner incision are basically bonded and healed, muscles at two sides of the incision have signs of atrophy, the muscles with the inner incision in the F group (with medicine) are completely bonded and healed, and the muscles at two sides of the incision are full and have no atrophy.
Typical case one:
forest XX, male, 10 years old, Wenzhou City in Zhejiang province. A1.2 cm deep wound (exposing white bones and muscles) is cut by a knife at a tiger's mouth between a thumb and an index finger in 7 months, then the wound is subjected to anti-inflammation by alcohol by a country doctor, and then the wound is bandaged by aseptic gauze soaked with the Jiemihuang amine (the wound is not sutured by needle threads), the wound is subjected to anti-inflammation bandaging by changing gauze 3 times (once every two days), the wound does not have any sign of adhesion healing in 7 days, and the epidermis on two sides of the wound surface has a sign of drying. On day 8, the three drugs of the example were used: 9 parts of dragon's blood, 14 parts of rosin, 14 parts of pearl powder, 9 parts of bezoar, 18 parts of sedum, 9 parts of bulbus fritilariae, 14 parts of borneol, 9 parts of musk, 9 parts of pseudo-ginseng, 16 parts of mint, 9 parts of viola and 17 parts of myrrh; grinding the above mixed materials in a grinder for 10 min to obtain medicinal powder, mixing with oleum Sesami, wrapping with sterile gauze (wound is not sutured with needle and thread), and healing after 5 hr and 1 day.
Typical case two:
yang XX, male, 32 years old, Wenzhou City in Zhejiang province. The dry mountain is farmed and alive in 10 months, the left arm is pricked and scratched carelessly without any anti-inflammatory treatment, after more than ten days, the whole arm generates pus, then a 1.5 cm-long incision is cut by a scalpel for rural doctors in the left hand to discharge pus, after 5 days, the pus is discharged, the head of the pus is discharged, the incision is spread by 1cm wide, and the incision cannot be healed. The four medicaments are used according to the embodiment: 9 parts of dragon's blood, 14 parts of rosin, 14 parts of pearl powder, 9 parts of bezoar, 18 parts of sedum, 9 parts of bulbus fritilariae, 14 parts of borneol, 9 parts of musk, 9 parts of pseudo-ginseng, 16 parts of mint, 9 parts of viola and 17 parts of myrrh. : 5 parts of dragon's blood, 15 parts of catechu, 3 parts of borneol, 10 parts of musk, 8 parts of pseudo-ginseng, 10 parts of rosin, 15 parts of bulbus fritilariae, 5 parts of calculus bovis, 5 parts of viola, 10 parts of rhizoma cibotii, 5 parts of menthol and 10 parts of pinellia ternate; grinding the uniformly mixed medicinal materials in a grinder for 10 minutes to obtain medicinal powder, uniformly scattering a small amount of the medicinal powder on two sides of an incision for multiple times, wherein the width of the incision is 0.2cm after the incision is healed after one day, and the incision is completely healed after two days.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and those modifications and variations assumed in the above are also considered to be within the protective scope of the present invention.
Claims (2)
1. The medicine for rapidly healing the surgical incision and promoting the growth of wound muscles is characterized by comprising, by weight, 5-10 parts of dragon's blood, 10-15 parts of rosin, 10-15 parts of pearl powder, 5-10 parts of bezoar, 10-20 parts of sedum aizoon, 5-10 parts of bulbus fritillariae cirrhosae, 10-15 parts of borneol, 5-10 parts of musk, 5-10 parts of pseudo-ginseng, 10-20 parts of mint, 5-10 parts of viola and 10-20 parts of myrrh.
2. The medicine for rapidly healing an operation incision and promoting wound muscle growth according to claim 1, characterized in that raw materials of the medicine comprise, by weight, 6-8 parts of dragon's blood, 12-14 parts of rosin, 11-14 parts of pearl powder, 6-9 parts of bezoar, 13-17 parts of sedum, 6-9 parts of bulbus fritilariae, 11-14 parts of borneol, 6-8 parts of musk, 7-9 parts of pseudo-ginseng, 14-18 parts of mint, 6-8 parts of viola and 12-15 parts of myrrh.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111383081.4A CN114042119A (en) | 2021-11-22 | 2021-11-22 | Medicine for quickly healing surgical incision and promoting wound muscle growth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111383081.4A CN114042119A (en) | 2021-11-22 | 2021-11-22 | Medicine for quickly healing surgical incision and promoting wound muscle growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114042119A true CN114042119A (en) | 2022-02-15 |
Family
ID=80210418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111383081.4A Pending CN114042119A (en) | 2021-11-22 | 2021-11-22 | Medicine for quickly healing surgical incision and promoting wound muscle growth |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114042119A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101428122A (en) * | 2008-12-10 | 2009-05-13 | 李金梅 | Traditional Chinese medicine powder for removing necrosis and promoting granulation, and preparation method thereof |
| CN102526411A (en) * | 2012-03-20 | 2012-07-04 | 许从玉 | Chinese medicinal composition for treating surgical wound |
| CN104257963A (en) * | 2014-09-13 | 2015-01-07 | 董亚利 | Medicine for preventing postoperative infection and scars |
| CN110384748A (en) * | 2019-05-30 | 2019-10-29 | 杨启祥 | A kind of weapons wound badu shengji powder |
-
2021
- 2021-11-22 CN CN202111383081.4A patent/CN114042119A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101428122A (en) * | 2008-12-10 | 2009-05-13 | 李金梅 | Traditional Chinese medicine powder for removing necrosis and promoting granulation, and preparation method thereof |
| CN102526411A (en) * | 2012-03-20 | 2012-07-04 | 许从玉 | Chinese medicinal composition for treating surgical wound |
| CN104257963A (en) * | 2014-09-13 | 2015-01-07 | 董亚利 | Medicine for preventing postoperative infection and scars |
| CN110384748A (en) * | 2019-05-30 | 2019-10-29 | 杨启祥 | A kind of weapons wound badu shengji powder |
Non-Patent Citations (2)
| Title |
|---|
| 王陆宽，等: "祛腐生肌治疗疮疡及创伤感染性疾病340例", 《中国民间疗法》 * |
| 陈英姿，等: "跌打七厘胶囊的质量标准研究", 《湖南中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018164757A (en) | New standardizations and medical devices for preparation of platelet rich plasma (prp) or bone marrow centrate (bmc) alone or in combination with hyaluronic acid | |
| CN106581736B (en) | Medical adhesive taking giant salamander body surface mucus as raw material and preparation method thereof | |
| Khorasani et al. | The effects of Aloe Vera cream on split-thickness skin graft donor site management: a randomized, blinded, placebo-controlled study | |
| CN107184961A (en) | A kind of competent cell renovation agent and preparation method thereof | |
| CN104940905A (en) | Medicine composition for promoting wound healing after operation and preparation method thereof | |
| JP7378486B2 (en) | Medical adhesives, their preparation methods, and their uses | |
| CN101264196B (en) | Externally-applied medicinal composition for treating surgical wound and preparation of ointment thereof | |
| Mariappan | Collagen dressing for thermal burns | |
| CN114042119A (en) | Medicine for quickly healing surgical incision and promoting wound muscle growth | |
| CN109700601A (en) | A kind of hydrocolloid silicon dressing patch | |
| CN105031622A (en) | Pharmaceutical composition capable of promoting wound healing, and preparation method thereof | |
| Leon-Villapalos et al. | Skin autografting | |
| CN1679682A (en) | Hemostatic mastic and formulating method thereof | |
| Hart | Wound management | |
| Dove et al. | Dressings of the nailbed following nail avulsion | |
| RU2312658C1 (en) | Film-forming aerosol for wound protection in treatment and method for its using | |
| CN109010906A (en) | A kind of biological glue and its working method for promoting postoperative wound local hemostasis and promoting postoperative wound epithelialization | |
| CN1418706A (en) | Glue for medical use | |
| US20240082314A1 (en) | Wound healing agents, methods for use and manufacture of the same | |
| CN111956859B (en) | Antibacterial hemostatic band-aid containing traditional Chinese medicine components and preparation method thereof | |
| CN1299747C (en) | Chinese medicine composition for treating red trauma and its preparing method | |
| CN1965889A (en) | Medicament for treating scald and burn and preparation method thereof | |
| Attinger | Soft tissue reconstructive options for the ulcerated or gangrenous diabetic foot | |
| Lin et al. | Reconstruction of Thumb Defects | |
| Kumari et al. | ROLE OF PRIYANGVADI TAILA IN THE MANAGEMENT OF DIABETIC WOUND-A CASE REPORT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220215 |